Key points
- In human trials of NAD+ precursors, the side effects reported are mostly mild and transient — gastrointestinal upset, headache, flushing, and fatigue — with no serious adverse events attributable to the supplement.
- Almost none of that safety data is specific to liposomal NAD+; it comes from oral nicotinamide riboside (NR) and NMN, so liposomal-specific tolerability is largely uncharacterized.
- Long-term safety (years of continuous use), very high doses, and use in specific medical conditions remain genuinely open questions.
Short answer: the side effects people report from liposomal NAD+ are usually mild, short-lived, and digestive — but the honest catch is that we have very little safety data on the liposomal form itself. What we know about tolerability comes overwhelmingly from trials of oral NAD+ precursors like nicotinamide riboside and NMN, where adverse events have been minor and comparable to placebo. Whether a liposomal delivery system changes that picture is largely untested. So the fair reading is "probably well tolerated for most people, with real gaps in the long-term and high-dose data."
What is liposomal NAD+, and why might it cause side effects?
Liposomal NAD+ wraps NAD+ (or a precursor) in tiny lipid spheres intended to survive digestion and improve absorption. The marketing logic is that better delivery means more of the compound reaches circulation. If that logic holds, it also means that any dose-related effects could, in theory, show up more readily — though this is an inference, not something trials have demonstrated for the liposomal form.
The mechanistic reason NAD+ supplements can produce side effects at all is that NAD+ sits at the center of energy metabolism, sirtuin signaling, and methylation. Nudging that system can produce short-term sensations — warmth, mild GI changes, headache — as the body adjusts. These are generally read as adaptation effects, not toxicity. If you want the broader context on how the liposomal delivery claim holds up, we cover it in our breakdown of whether liposomal NAD+ absorption actually delivers.
What side effects do people actually report?
Across consumer reports and the clinical literature on NAD+ precursors, the same short list recurs: nausea, bloating or loose stools, mild headache (sometimes with morning dizziness), transient flushing or skin warmth, occasional sleep changes, and fatigue. They tend to appear in the first few days to weeks, are more likely at higher doses or when starting abruptly, and usually fade as the body adapts. Taking the supplement with food and earlier in the day are the most commonly cited ways to reduce them.
Study snapshot — safety systematic review
A 2022 systematic review pooled 10 studies (489 participants) of NADH and NAD+ precursors across conditions including chronic fatigue, Parkinson's, prediabetes, and older adults. The most common side effects were muscle pain, sleep disturbance, fatigue, and headache — and the authors concluded none of the cataloged adverse events posed a serious risk to participants.
What human studies actually show
A 2022 systematic review found mild, non-serious side effects only. Reviewing 10 studies and 489 participants taking NADH or NAD+ precursors, the most frequently reported effects were muscle pain, nervous-system complaints, fatigue, sleep disturbance, and headache. Crucially, the authors judged that none of the adverse events represented a serious health risk (PMID 37971292). This is reassuring, but note: it pools oral precursors, not liposomal NAD+.
Dedicated NR trials report excellent safety. In a 12-week randomized, placebo-controlled trial, 40 obese men took 1,000 mg of nicotinamide riboside twice daily; the supplement was safe and well tolerated, with adverse events comparable to placebo (PMID 29992272). NR is one of the two best-studied NAD+ precursors, and trials like this anchor the "generally well tolerated" conclusion.
The honest counterweight — an animal-data caution about existing cancers. A clinical-trial informed-consent document for an NR study in older adults flagged that while NAD+-boosting compounds may help prevent cancer in some animal models, a few animal reports suggest they could promote the growth of cancers that are already present (NCT03482167). This has not been demonstrated in humans, and the relevance to supplementation is unknown — but it is a real reason that anyone with a current or recent cancer diagnosis should talk to their oncologist before using any NAD+ product. We discuss the broader safety record in our overview of what the trials report on NAD+ supplement side effects and, specifically for the precursor, nicotinamide riboside side effects.
What liposomal NAD+ side-effect data won't tell you
Here is the limitation worth being blunt about: the reassuring safety profile above is for oral NR and NMN, not for liposomal NAD+. Liposomal products are relatively new, and there is no body of randomized trials characterizing their specific tolerability, long-term safety over years, or behavior at very high doses. Liposomes themselves are well established as a delivery technology, but "the ingredient is safe" and "this particular delivery format at this dose over this duration is safe" are different claims.
Some side effects can also have medical causes that a supplement won't fix and might mask. Persistent headaches, ongoing GI symptoms, palpitations, or new fatigue deserve a doctor's evaluation rather than a dosing tweak — see a clinician if symptoms are severe, persistent, or accompanied by anything that worries you. People who are pregnant or breastfeeding, who have a methylation-related condition, or who take prescription medications should get individualized advice before starting.
How to reduce the odds of side effects
The trial doses that established NAD+ precursor safety cluster around 300–1,000 mg per day of NR, with some studies using up to 2,000 mg. Most consumer side-effect reports track with starting high or fast. Practical, evidence-aligned steps: start at the lower end of a product's range, take it with food, dose in the morning rather than at night, stay hydrated, and give your body a week or two to adapt before judging tolerability. If a symptom is more than mild or doesn't settle, stop and reassess.
Frequently asked questions
Does liposomal NAD+ cause more side effects than regular NAD+ supplements?
There's no head-to-head trial answering this. In theory, better absorption could make dose-related effects more noticeable, but that's an inference. In practice, the reported effects are the same short list of mild, transient symptoms seen with oral precursors.
Why do I get a headache when I start?
Mild headache is one of the most commonly reported early effects and usually resolves within about a week. Taking the dose with food and water, and not on an empty stomach, is the most frequently cited fix. A headache that's severe or persistent is a reason to stop and check with a clinician.
Is the flushing the same as niacin flush?
Not necessarily. The intense, well-known "niacin flush" is specific to nicotinic acid. NAD+ precursors like NR and NMN are not associated with that classic flush, though some people report transient warmth. If you want the comparison, our NR side effects article covers it.
Should anyone avoid it entirely?
People who are pregnant or breastfeeding, those with a current or recent cancer diagnosis, and anyone on prescription medication or managing a chronic condition should talk to a clinician first. The animal cancer-growth signal, while unproven in humans, is reason enough for caution in that specific group.
Are there long-term risks?
Honestly, we don't fully know. Most studies run weeks to months, so multi-year continuous use hasn't been well characterized — for any oral form, and especially not for liposomal NAD+.
From Nuvirox
Why we formulated NAD+ Restore
We built NAD+ Restore around 500 mg of Nicotinamide Riboside Chloride (NR) per 2-capsule serving — one of the two most-researched NAD+ precursors, within the dose range used in published human trials. We pair it with 150 mg trans-resveratrol (Japanese Knotweed) and 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support — plus 10 mg galactomannans from fenugreek to support absorption. It ships with a 60-day money-back guarantee, long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
The side effects associated with NAD+ supplementation are, by the available evidence, mild and short-lived — digestive upset, headache, transient warmth, occasional sleep changes — with no serious adverse events linked to the supplement in human trials. The genuine caveat is that this safety record belongs to oral NR and NMN, not specifically to liposomal NAD+, which simply hasn't been studied the same way. Start low, take it with food, give it a couple of weeks, and loop in a clinician if you have a medical condition, take medications, or notice anything more than mild. The honesty is the point: well tolerated for most, with real unknowns at the edges.
References
- Pieri M, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Int J Mol Med. 2024. PMID: 37971292.
- Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343–353. PMID: 29992272. DOI: 10.1093/ajcn/nqy132.
- NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment (informed consent). ClinicalTrials.gov: NCT03482167.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.